Leukemia Research
Издатель: Elsevier · ISSN 0145-2126 · 52 статей
- Immune-mediated thrombosis in myeloproliferative neoplasms: Pathogenic pathways and clinical relevance
- Functional substitution of imatinib-inactivated canonical oncoprotein BCR::ABL1 by overexpressed PLAG1 results in BCR::ABL1-independent resistance in blast phase of chronic myeloid leukemia
- Intensive induction chemotherapy in adult acute myeloid leukemia: A single centre assessment of complete remission and induction mortality
- Risk of subsequent primary acute myeloid leukemia after breast cancer: A population-based analysis of 608,268 women in the SEER Program
- SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics
- Clinical characteristics and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A final report of CML Cooperative Study Group
- HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next‐Generation Therapies
- Comorbidity burden is a major independent prognostic factor in Waldenström Macroglobulinemia: A national cancer database retrospective study
- Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis
- Advances in diagnosis and treatment of angioimmunoblastic T-cell lymphoma
- Outpatient step-up dosing of teclistamab and talquetamab in relapsed or refractory
- Integrating a clinical database and institutional biobank to map the epidemiological landscape and survival outcomes of lymphoma in Saudi Arabia
- Multiple and central nervous system extranodal involvement predict poor prognosis in R/R DLBCL following CD19 CAR-T therapy
- Cyclophosphamide maintenance in multiple myeloma without transplantation: A real-world study
- Hypogammaglobulinemia is a class effect of bispecific T-cell engagers: A Bayesian disproportionality analysis of a national database
- Tracing the Clonal Origin of VEXAS: Insights from cases of myelofibrosis with concurrent UBA1 and JAK2 V617F mutation
- Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leukemia
- A novel BCR::ABL1 I502T mutation associated with acquired asciminib resistance in CML
- Momelotinib induces hemoglobin improvement and symptom control in PCM1::JAK2-associated myeloid neoplasm
- Luvometinib as a salvage therapy for a patient with PTPN11-positive juvenile myelomonocytic leukemia
- Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study
- CDC20 and CEP55: essential players for pathogenesis of chromosomal abnormalities in MDS?